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ABSTRACT  
Research has investigated testosterone and its role in biological and psychological 
functioning.  Testosterone levels decrease as men age, and aging has been associated with 
declines in muscle mass and strength.  Decreased functional mobility can impact quality 
of life.  Aging has also been associated with increased vulnerability to depressive 
symptomatology.  The purpose of this study was to investigate interrelationships among 
testosterone, physical functioning, quality of life, and depression in the Vietnam Era 
Twin Study of Aging (VETSA).  The mean age of the 1,237 men in VETSA was 55.4 
(+2.5).  Testosterone data collection began in the third year of VETSA, yielding an 
available sample of 778.  
It was hypothesized that there would be significant associations between testosterone and 
physical functioning, depression, and quality of life as well as between physical 
functioning and depression and quality of life.  Contrary to expectations, when mixed 
models for linear regression were used, testosterone was shown to be related only to 
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physical functioning.  As predicted, however, physical functioning was significantly 
related to depression and quality of life.   
Cholesky decompositions were conducted to address the hypothesis that there were 
shared genetic determinants of each phenotype.  Best fitting bivariate models included 
additive genetic and unique environmental but not common environmental influences.  
Significant genetic correlations were found between physical functioning and depression, 
and physical functioning and the mental health component score of the Short Form 
Health Survey (SF-36).  Contrary to expectations, while testosterone and physical 
functioning were significantly correlated with each other phenotypically, there was no 
genetic correlation between the two.  Trivariate models revealed genetic influences 
specific to depression as well as genetic influences shared with quality of life and 
depression. 
Finally, path analysis demonstrated that testosterone had a direct impact on physical 
functioning.  Physical functioning, but not testosterone, directly impacted depression and 
quality of life.  As there was no genetic correlation between testosterone and physical 
functioning, but there was a phenotypic correlation, it may be that other factors, such as 
cortisol, influenced the association.  In sum, in this sample, physical functioning seemed 
to be more important than testosterone to both depressive symptomatology and quality of 
life.   
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Chapter One – Introduction and Methods 
Introduction 
Copious research has been conducted to investigate testosterone and its role in 
various aspects of functioning.  Testosterone levels are known to decrease as men age, 
even in those men who are otherwise healthy.  While the depletion of hormones is more 
abrupt for women during menopause, the decline is gradual and steady in men.  
Typically, the decline starts when men are in their 20’s and is continuous throughout the 
lifetime (Brown, 2008).  The decline in testosterone availability can manifest clinically in 
the sixth and seventh decade of life (Bain, 2007).  The proportion of men with 
testosterone levels below the norm for younger men has been found to be 7% of men in 
their 40’s and 50’s and about 20% for men aged 60 up to 50% for men aged 80 
(Gruenewald & Matsumoto, 2003; Morley, 2000).   For men, the process of aging has 
been associated with cognitive decline, decreased muscle mass, osteopenia and loss of 
strength in addition to decreased libido and erectile dysfunction (Morley, 2000).  Some of 
these age-related problems may be more clearly related to testosterone levels, while the 
causes of others are still somewhat controversial.  Some researchers have proposed that 
age-related testosterone decline may be a part of a larger syndrome such as late-onset 
hypogonadism or andropause (Wu et al., 2010).   
 In addition to age-related decline, a number of other factors can have a deleterious 
effect on testosterone levels.  These include obesity, inactivity, diet, disease, and trauma 
(Brown, 2008).  Furthermore, testosterone levels have been shown to be highly heritable, 
with estimates of up to 56% (Kuijper et al., 2007).  Others have also found the heritability 
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of testosterone to be around 60% in adolescent males, with no resemblance in father-son 
values (Harris, Vernon, & Boomsma, 1998).  This suggests that different genetic factors 
may be expressed at different ages and that the heritability of testosterone may change 
with age.  For a hormone that has typically been thought of as the male ‘sex hormone’ the 
implications for its depletion are more far-reaching than the effects on sexual desire and 
arousal (Bain, 2007).  Testosterone can play a myriad of roles from early intrauterine life 
through puberty into senescence. 
Testosterone’s relationship to Quality of Life and Depression 
 Some researchers have utilized specific groups to investigate the correlates of 
androgen deficiency.  For example, a sample of 176 young male cancer survivors was 
compared to 213 male controls to elucidate the role of testosterone in quality of life 
(Greenfield et al., 2010).  The men in the sample were all off treatment and in remission 
for at least two years for cancers that were non-hormone dependent.  The breakdown of 
cancer type was approximately 41% for lymphoma, 39% germ cell, and 20% other 
(which included leukemia, gastrointestinal, brain, sarcoma, and skin).  Not unexpectedly, 
for young men with cancer, even if serum testosterone levels were in the normal range, 
the quality of life scores were lower than for the controls.  However, beyond the impact 
of cancer, testosterone levels had specific consequences on quality of life.  In the group 
with cancer, there were varying levels of testosterone.  The men who met criteria for 
hypogonadism (testosterone levels < 10 nmol/L) reported worse quality of life scores 
compared to those who did not meet criteria for hypogonadism (Greenfield et al., 2010). 
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In contrast, in a pilot study of healthy men, 65 or older, Reddy, White, Dunn, 
Moyna, and Thompson (2000) measured the quality of life for men who received either a 
placebo or an intramuscular dose of testosterone.  Quality of life was assessed via the 
Short Form 36 item health survey (SF-36) three times during the study (at baseline, week 
8 and 6 weeks after the last dose).  For the men in this study, there was no change within 
group over time nor was there any difference between the experimental or control groups 
(Reddy et al., 2000).  Reddy et al. (2000) concluded that intramuscular testosterone 
administered over eight weeks did not have a beneficial effect on health-related quality of 
life for elderly men.  However, because this was a pilot study, the small sample size 
(n=14 for testosterone, n=8 for placebo) may not allow for smaller changes to be 
detected. 
 Other research has demonstrated that the administration of testosterone improves 
quality of life for men with Alzheimer’s disease (AD; Lu et al., 2006) .  In this study, 16 
men with AD and 22 controls were randomized to receive testosterone supplements or a 
placebo.  While there were no significant improvements in cognition in the treatment 
groups, in the AD treatment group the caregiver-rated quality of life was significantly 
greater than for the placebo group. The non-AD group who received testosterone also had 
a trend toward improved quality of life (self-report), but this did not reach significance 
(Lu et al., 2006).  A similar pattern was seen in men with HIV-related weight loss.  For 
the HIV positive men who received testosterone, compared to those who received a 
placebo, there were significant improvements in mental health and quality of life (Knapp 
et al., 2008).   
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 For men receiving morphine treatment for chronic pain, hypogonadism is a 
common occurrence and a side effect with significant consequences.  In one study, over a 
period of a year, men with opioid-induced hypogonadism were treated with daily 
application of testosterone gel (Aloisi et al., 2011).  With the increase of total and free 
testosterone in these men, mental health evidenced a significant improvement over time.  
Furthermore, the pain rating indexes as well as sexual functioning also displayed 
significant improvement (Aloisi et al., 2011). 
 Some have demonstrated that middle-aged men with depression had decreased 
levels of testosterone (McIntyre et al., 2006) and others have shown improvement of 
depressive symptoms with testosterone replacement therapy (Pope, Cohane, Kanayama, 
Siegel, & Hudson, 2003).  On the other hand, Seidman et al. (2002) found testosterone to 
be related only to dysthymia (not major depression), while others have not found a 
relationship between testosterone and mood at all (Gray et al., 2005; Reddy et al., 2000). 
 In a historical study, Shores et al. (2004) reviewed medical records from the 
Veteran’s Affairs Puget Sound Health Care System to assess testosterone levels and 
depression over a two year period.  Excluding men who were taking an antiandrogen 
therapy or who had previously been diagnosed with depression, Shores et al. (2004) 
classified men as either hypogonadal or eugonadal based on their testosterone levels.  
From the computer records, they were able to find 294 men who had never been 
diagnosed with depression but had testosterone results that were consistent (repeated low 
or repeated normal results on separate occasions).  The hypogonadal and eugonadal 
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groups were not different from each other in terms of age, ethnicity, alcohol disorders, 
prostate cancer, chronic disease scores or clinic visits.  Shores et al. (2004) found that 
over a two year follow up, the hypogonadal men had a significantly increased occurrence 
of depression compared to the eugonadal men and the hypogonadal men also had a 
significantly shorter time to depression (Shores et al., 2004). 
 Seidman et al. (2002) compared testosterone levels in three groups of elderly men 
who met diagnostic criteria for either major depressive disorder or dysthymic disorder or 
a control group who scored below the median on the Center for Epidemiologic Studies 
Depression Scale.  Interestingly, the men with dysthymic disorder had significantly lower 
testosterone levels compared to those of men with major depressive disorder and men 
with no depression.  Others have found that men with depression are more likely to have 
total and free testosterone levels in the lowest quintile (Almeida, Yeap, Hankey, 
Jamrozik, & Flicker, 2008).  The association between low levels of testosterone and 
increased depression could not be sufficiently explained by physical comorbidity.  Men 
in the lowest quintile of free testosterone levels were three times as likely to have 
depression compared to the men in the highest quintile, even after controlling for 
potential confounds (Almeida et al., 2008). 
However, not all studies have found a relationship between testosterone and 
mood.  For example, in a study measuring the impact of testosterone administration, Gray 
and colleagues did not find a dose-dependent effect on depressed or manic symptoms in a 
sample of sixty healthy older men, aged 60 – 75 (Gray et al., 2005).   
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Testosterone and Physical Functioning 
 Many studies have shown that there is relationship between testosterone and 
physical functioning.  Testosterone is known to play a role in the health of skeletal 
muscle and bone in both men and women; there is evidence that the loss of testosterone is 
associated with decline in both.  Low testosterone is correlated with poor muscle strength 
(Brown, 2008). 
 Some research has established a causal relationship between muscle mass and 
testosterone, such that body composition changes according to the administration or 
deprivation of testosterone supplements (Slowinska-Lisowska, Jozkow, & Medras, 2010).  
However, in a sample of men aged 24 to 72, it has been shown that the reverse is not true, 
physical activity does not influence concentrations of testosterone (Slowinska-Lisowska 
et al., 2010).  The consequences of lower testosterone on muscle mass and strength may 
be apparent beyond physical activity.  In a longitudinal study of 2,587 community-based 
men, lower levels of testosterone have been associated with higher fall risk (Orwoll et al., 
2006).  This association was independent of poor physical performance. 
 However, not all studies have found an association between testosterone and 
physical functioning (Schaap et al., 2008; Storer et al., 2008).  In a clinical trial 
measuring the effect of testosterone administration, 44 healthy men (aged 60-75 years) 
received gonadotropin releasing hormone agonist as well as 25, 50, 125, or 300 mg/wk 
testosterone over the course of 20 weeks.  Measurements of physical functioning 
included estimations of skeletal muscle mass as well as leg strength, leg power, and 
muscle fatigability.  In addition, the physical functioning assessment consisted of stair 
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climbing, walking speed, and a timed-up-and-go task.   While testosterone-dependent 
increases on skeletal muscle mass and strength were evident, the other measures were not 
susceptible to testosterone application.  Administration of testosterone was not found to 
be associated with improvements in muscle fatigability or physical functioning, in spite 
of substantial gains in skeletal muscle mass.    The authors suggested that because the 
sample of men was already high-functioning, their performance on the physical 
functioning measures may have reached an asymptote, beyond which gains in strength no 
longer have benefit (Storer et al., 2008).    
 In a sample of 108 men over the age of 65, who were at least one standard 
deviation below the mean for normal young men, Snyder et al. (1999) performed a 
double-blind study.  The men were randomized to wear either a transdermal testosterone 
patch or a placebo patch over a 36 month trial.  While the men in the treatment group saw 
gains in lean mass (primarily in the trunk) and decreases in fat mass (primarily in the 
arms and legs), the testosterone did not improve physical functioning, nor did it increase 
grip strength or knee flexion.  In this sample, returning testosterone levels for older men 
to those in a mid-normal range for younger men did not improve physical functioning 
(Snyder et al., 1999).  However, others have demonstrated that the administration of 
testosterone can be more beneficial when it occurs concurrently with the administration 
of growth hormone (Giannoulis et al., 2006) 
 Some research has shown that, in normal healthy older men, when testosterone 
application is supplemented by a strengthening program, there are significant 
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improvements in domains of the SF-36 that relate to physical functioning (Katznelson, 
Robinson, Coyle, Lee, & Farrell, 2006).  Neither testosterone alone nor exercise alone 
demonstrated an effect on quality of life or body composition.  However, an interaction 
between the two resulted in improvements in the SF-36 domains including: physical 
functioning, limitations in usual role due to physical problems, general health and social 
functioning (Katznelson et al., 2006) . 
Physical Functioning and Depression 
 One widely used assessment of physical functioning, hand grip strength, targets 
upper body strength.  Previous research has found that grip strength differs between men 
and women and decreases with age (Carmeli, Patish, & Coleman, 2003; Carmelli & 
Reed, 2000; Frederiksen et al., 2002; Jeune et al., 2006; Shechtman, Mann, Justiss, & 
Tomita, 2004).  Significant associations with gender have been established, wherein 
males initially perform better but have a significantly higher rate of decline (Finkel et al., 
2003).  Decreased grip strength is a predictor of disability and is associated with frailty 
and mortality (Giampaoli et al., 1999; Rantanen et al., 1999; Syddall, Cooper, Martin, 
Briggs, & Aihie Sayer, 2003).  Rantanen and colleagues (1999) found that midlife grip 
strength values in healthy men were predictive of both functional limitations and 
disability measured 25 years later.   
By applying latent growth curve models, Finkel et al. (2003) investigated 
trajectories of change along with genetic and environmental contribution to various 
biomarkers of aging.  Grip strength, along with lung functioning and blood pressure 
showed monotonic changes with age.  Heritability estimates revealed a pattern wherein 
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genetic and shared environmental variance remained stable over time while non-shared 
environmental components decreased (Finkel et al., 2003).  This pattern is characteristic 
of other studies as well (Carmelli & Reed, 2000; Frederiksen et al., 2002). 
Some have also attempted to establish a relationship between physical functioning 
and depressive symptoms.  In a sample of 379 elders in Brazil, Reichert, Diogo, Vieira, 
and Dalacorte (2011) analyzed depressive symptom and physical activity.  For men, those 
who had higher levels of physical activity also had lower occurrences of depressive 
symptoms.  For the men who were in the very active group, the odds ratio of depressive 
symptoms was 0.32 compared to that of the insufficiently active group.  This pattern was 
not seen in the women of the study (Reichert et al., 2011).  
Physical functioning is an important component of one’s functional health.  Upper 
body strength is required for some of the basic activities of daily living (ADL; (Katz, 
1983) as well as many of the Instrumental ADLs of the Lawton-Brody scale (Lawton & 
Brody, 1969).  In addition to affecting one’s self-care and homemaking abilities, 
impaired strength may impact leisure activities, decreasing one’s quality of life.   
The age-related decline in testosterone has been associated with physical 
functioning as well as depressive symptomatology, although the results are mixed.  The 
purpose of the present study is to investigate the relationships among testosterone, 
physical functioning, quality of life (as measured by the SF-36) and depression (as 
measured by the CES-D) in men aged 51 to 60.  Because the sample is made up of twin 
pairs, this will be the first study to investigate a genetic contribution to all four 
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phenotypes.  Additionally, previous research has not explored the interplay, if any, 
among all four phenotypes together.   
More research is necessary to confirm the role of testosterone as well as optimal 
levels for functioning.  Several studies have results that may be evidence for an optimal 
level of testosterone.   Testosterone levels, and their impact on functioning, have 
implications for both clinical populations with true hypogonadism as well as the general 
aging population with declining testosterone.  Determining the role testosterone plays in 
depression, quality of life and physical function allows for possible treatment with 
testosterone administration to improve one’s overall functioning.   
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Methods 
Subjects 
 The present study is a sub-study of the Vietnam Era Twin Study of Aging 
(VETSA 1: 2002-2008).  The VETSA is conducted at Boston University (BU) and the 
University of California at San Diego (UCSD).  A complete description of the VETSA is 
available elsewhere (Kremen et al., 2006).    The VETSA twins are members of the 
Vietnam Era Twin Registry (VETR), a national sample of male twin pairs in which both 
served in the U.S. military during the Vietnam Era (1965-1975).  Members of the VETR 
are representative of all twins who served in the military during the Vietnam War on a 
variety of socio-demographic variables (Eisen, Neuman, Goldberg, Rice, & True, 1989); 
(Goldberg, True, Eisen, Henderson, & Robinette, 1987). Nearly half (48.5%) of the 
individuals contacted agreed to participate in the VETSA.  Since participation in VETSA 
requires a 2- or 3-day commitment to travel to either BU or UCSD, we believe that the 
48.5% participation rate is reasonable.  The demographics of the VETSA sample are very 
similar to other men in their 50’s as measured by the United States census data from 2003 
in terms of education, income, ethnicity, marital status, and employment.  Although all 
VETSA participants were members of the military, two-thirds of them were not stationed 
in a war zone (Lyons et al., 2009). 
 The mean age of the 1,237 participants in the VETSA was 55.4 + 2.5 (range 51 – 
60).  The vast majority of VETSA participants were assessed at one of the two testing 
sites (BU or UCSD).  In rare circumstances, some participants required a research 
assistant travel to their home town for testing at a local hotel in a conference room. 
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Informed consent was obtained according to the guidelines of the Institutional Review 
Boards at BU and UCSD. 
 During the third year of the VETSA project, we added a component to test 
Hypothalamic-Pituitary-Axis (HPA) regulation.  The purpose of the sub-study was to 
assay saliva to ascertain levels of cortisol, testosterone, and DHEA.  At the 
commencement of this study, 795 participants were available for inclusion.  Of the 795, 9 
eligible twins declined to participate, saliva samples of 3 twins were lost or spilled, and 5 
twins had samples that were missing more than one assay on a single day yielding a final 
available sample of 778 (Franz et al., 2010).  
Measures 
Table 1.1 reflects the descriptive statistics for each of the following measures. 
Testosterone  
 The protocol for collecting the saliva samples has been described in detail 
elsewhere (Franz et al., 2011; Franz et al., 2010).  Briefly, the twins provided five saliva 
samples on two non-consecutive days at home, approximately 2 weeks prior to their 
arrival at the test site.  The participants were asked to provide saliva samples on a 
schedule designed to mirror circadian rhythm but also according to their usual daily 
schedule corresponding to: immediately upon awakening, 30 minutes after awakening, 
1000 h, 1500 h, and 2100 h (or bedtime).  For the day-of-testing samples, participants 
arrived at the hotel the evening prior to testing and were given the saliva sample materials 
at that time.  Once again, the participants provided samples immediately upon awakening 
and 30 minutes after awakening.   The 1000 h and 1500 h samples were collected in the 
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laboratory and the bedtime samples were again provided at the hotel.  The samples 
collected in the laboratory were given in between specific tests (rather than exactly at 
1000 h and 1500 h) to ensure standardization.  All protocols are standardized across 
testing sites.  Immediately following each saliva sample, participants completed a written 
log.  In this log, participants were asked to indicate their mood, anything they had to eat 
or drink, medications, and activities.  Saliva samples were shipped to the University of 
California at Davis for the assay.  The average testosterone over three days will be used 
for these analyses (Panizzon et al., 2010). 
Physical Functioning 
The physical functioning score is a latent factor derived from factor analysis of 
several tests, including: Grip Strength, Rise from Chair, Walk Test (10 meter speed 
walk), and Pulmonary Functioning (maximum forced expiratory flow).  The 
measurements for all of these protocols are standardized across testing sites.  Grip 
strength was measured through the JAMAR© hand dynamometer.  The participants were 
instructed to remain in a seated position with their arms resting on a table at a 90 degree 
angle so that their wrists were at the edge of the table.  Three measurements were taken 
from each hand, alternating hands.  The grip strength variable was calculated using the 
average of both hands.  Hand grip strength is a simple test that is widely used as a 
measure for hand and forearm strength, an assessment of functional capacity, and as a 
marker of aging (Anstey & Smith, 1999; Carmelli & Reed, 2000; Christensen et al., 
2000; Christensen, Mackinnon, Korten, & Jorm, 2001; Finkel et al., 2003; Frederiksen et 
al., 2002).  Grip strength is also used in conjunction with other measures to develop a 
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composite score of physical functioning (Deary, Whalley, Batty, & Starr, 2006) as was 
done in the present study.  Rise from Chair (RFC) task is a test of functional mobility in 
which the participant is asked to stand up from a chair as fast as possible, as many times 
as possible, in a 30 second time frame.  The RFC variable reflects the number of 
completed sit-stands in this window.  The Walk Test requires subjects to walk 10 meters 
as quickly as possible without running.  Finally, the maximum forced expiratory flow 
(FEF-max) was measured using Breeze© software.  FEF-max is one aspect of pulmonary 
functioning that represents the peak expiratory flow.  Pulmonary functioning has been 
validated as one measure of aging and has been associated with a number of health 
outcomes including activities of daily living (Tinetti et al., 2011).  Peak expiratory flow 
has been shown to be correlated with other aspects of physical functioning as well as 
cognition (Cook et al., 1995).  These four variables are significantly correlated in this 
sample (see Table 1.2). 
Depression 
Center for Epidemiological Studies – Depression Scale (CES-D; Radloff, 1977) 
Finally, depression scores are calculated from the Center for Epidemiological Studies – 
Depression Scale (CES-D; Radloff, 1977 ).  The CES-D was developed for use in the 
general population.  The items were pulled from previously validated scales.  In the initial 
field tests, internal consistency was high in both general and patient populations; it was 
able to discriminate between the two, as well. (Radloff, 1977).  Test-retest correlations 
are moderate, but as it is designed to measure current symptoms of depression it is not 
unexpected that these might change over time and circumstance (Radloff, 1977)  While 
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the CES-D has been shown to be both reliable and valid for measuring depressive 
symptomatology, some have argued that it does not adequately screen for clinical or 
major depression (Roberts, Vernon, & Rhoades, 1989).  The CES-D is a self-report 
questionnaire comprised of six scales which are intended to capture major aspects of 
depression: depressed mood, feelings of guilt and worthlessness, feelings of helplessness 
and hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance 
(Radloff, 1977).  The VETSA participants also completed this assessment prior to their 
arrival at the testing site. 
Quality of Life 
Short Form Health Survey (SF-36; Ware & Sherbourne, 1992) 
General health and Quality of Life scores were calculated from the 36 Item Short-
Form Health Survey (SF-36).  The SF-36 was designed for self-administration by 
individuals over the age of 14 and is intended for use in patient and general populations 
(Ware & Sherbourne, 1992).  It is a shorter version of a more comprehensive 
questionnaire and is both reliable and valid in the short form (Ware & Sherbourne, 1992).  
The VETSA participants completed the survey at home as part of a larger psychosocial 
questionnaire before they came to the testing site.  The SF-36 scales assess eight health 
concepts, including: limitations in physical activities because of health problems, 
limitations in social activities because of physical or emotional problems, limitations in 
usual role activities because of physical problems, bodily pain, general mental health, 
limitations in usual role activities because of emotional problems, vitality and general 
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health (Ware & Sherbourne, 1992).  These eight concepts are combined to form two 
composite measures, one for physical health (PCS) and one for mental health (MCS).  
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Table 1.1. 
Descriptive statistics for all measures 
Measure     N        SD  range 
Physical Functioning    992    0    1.00        (-2.87 – 3.21) 
Testosterone     749           100.42  30.30        (14.71 – 238.89) 
PCS    1224  50.12    8.53        (18.78 – 67.65) 
MCS       1224  51.74    9.02        (10.83 – 67.42) 
Depression       1231    8.30    8.25               (0 – 52)  
Note. “PCS”=Physical component score of the SF-36, “MCS”=Mental health component 
score of the SF-36. 
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Table 1.2. 
Correlations for four variables that comprise the latent Physical Function factor 
   Grip       RFC Walk       FEFmax 
Grip       1        
RFC      .242          1   
Walk       .217       .411    1  
FEFmax  .162       .127 .186          1 
 
Note. Significant p-values (<.01) are presented in bold, “Grip”=grip strength, 
“RFC”=rise from chair test, “Walk”=walk test, “FEFmax”=maximum forced expiratory 
flow. 
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Chapter Two – Mixed Models 
Introduction 
 Research regarding testosterone and physical functioning, mood, and quality of 
life has been somewhat mixed.  Often, putative relationships are explored in men who are 
less than healthy.  In addition, much of the research has focused on clinical trials, 
investigating the implications of testosterone administration.  To my knowledge, this is 
the first study to explore all four of the phenotypes in one sample of healthy, middle-aged 
men. 
Methods 
Participants 
 The participants included in the present analyses are the subset of the VETSA 
sample used to test HPA regulation, detailed in Chapter 1.  This included a final available 
sample of 778 (Franz et al., 2010) 
Procedure 
 The procedure of the present study does not differ from the VETSA procedure 
described in detail in Chapter 1. 
Materials 
 The materials included in the present analyses are the same as those detailed in 
Chapter 1. 
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Data Analysis: Mixed Models 
 Data analysis for the subjects and measures was completed utilizing mixed 
models for linear regression analysis.  Linear mixed models allow for analyses of non-
independent data from pairs of twins.  They have been validated for use in twin studies 
and the parameter estimates can be interpreted as if they were estimates from a standard 
regression model (Carlin, Gurrin, Sterne, Morley, & Dwyer, 2005).  Furthermore, for 
analyses that included testosterone, linear mixed models are able to account for possible 
correlated data between batches of assayed saliva in addition to correlated data between 
the twins. 
Models with significant associations were re-run with control variables (age, 
smoking, and health variables).  The smoking variable was a yes/no for current smoking.  
The health variables used as control variables were: hypertension, diabetes, and 
cardiovascular problems.  Subjects were classified as having hypertension (yes or no) if 
they were diagnosed by a doctor as having hypertension, were taking medication for 
hypertension, or if four measured blood pressures were greater than 140 over 90.  
Subjects were classified with diabetes (yes or no) if they were diagnosed by a doctor as 
having diabetes or if they were taking a diabetic medication.  Finally, subjects were 
classified as having cardiovascular problems (yes or no) if they were ever told they had 
had a heart attack, heart failure, peripheral vascular disease, or a stroke, or if they ever 
underwent heart catheterization, heart angiography, or heart surgery.   
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Statistical Power 
 Data from the full sample for the present study were already collected.  In order to 
ensure that there were enough participants to detect significant effects, a power analysis 
was conducted for the proposed analyses.  The GPower software package (Erdfelder, 
Faul, & Buchner, 1996) was used to explore the power of the regression models with up 
to seven predictor variables. If seeking to attain 80% power at an alpha level of .05, 725 
participants would be necessary to detect a small effect size (defined as f
2
=.02). For the 
present study, data are available for 778 participants. Given this sample size, it is possible 
to detect an effect size of f
2
=.0186, approximately the cut-off for effects classified as 
“small.” The number of participants in this sample makes it unlikely that even small 
regression effects would not be detected. 
Hypotheses 
 Testosterone levels would be a significant predictor of physical functioning 
(latent factor), depressive symptoms, and quality of life (the mental and 
physical composite scores of the SF-36). 
 Physical functioning would be a significant predictor of depressive symptoms 
and quality of life (the mental and physical composite scores of the SF-36). 
 These models would remain significant controlling for age, smoking, and 
overall health. 
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Results 
For the first part of the analyses, the relationships between the constructs were 
explored via linear mixed models with no covariates included in the models.  Several 
significant relationships were found (see Table 2.3).  Testosterone was shown to be 
associated with physical functioning such that higher levels of testosterone are associated 
with higher levels of physical functioning.  Testosterone was not significantly associated 
with any other dependent variable.  Physical functioning was shown to be negatively 
associated with depression and positively associated with the SF36 mental health 
component score.  Additionally, as one might expect, the measured latent variable of 
physical functioning was shown to be strongly positively associated with the self-
reported physical component score of the SF-36. 
In the second part of the analyses, significant relationships found in part one were 
again subjected to mixed model analyses.  This time, covariates were included in the 
model to determine if the relationships remained significant after controlling for 
confounding health variables that could influence the associations.  The covariates 
included age, smoking, hypertension, cardiovascular problems, and diabetes.  
Frequencies of these health variables in the current sample can be found in Table 2.4.  
With these covariates included in the mixed models, all significant relationships remained 
consistent (see Table 2.5). 
Discussion 
The goal of these initial analyses was to investigate the relationships between 
testosterone, physical functioning, depression, and quality of life.  It was hypothesized 
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that testosterone would be related to physical functioning, depression and quality of life.  
Also, it was predicted that physical functioning would be related to depression and 
quality of life. 
Contrary to expectations, testosterone was shown to be related only to physical 
functioning and not depression or quality of life.  In the literature, findings for a 
relationship between testosterone and other outcomes have been quite mixed.  Several 
studies have shown that there is a relationship between testosterone and skeletal muscle 
and bone as well as muscle strength (Brown, 2008).  However, not all studies have found 
an association between testosterone and physical functioning (Schaap et al., 2008; Storer 
et al., 2008).  Many of these studies are clinical trials in which healthy men have their 
testosterone production suppressed and subsequently replaced.  It may be that this 
artificial way of mimicking testosterone production is insufficient for establishing a true 
causal relationship.  In the current sample of middle –aged twins, there is a positive 
relationship between average testosterone levels and physical functioning.  This 
relationship remains significant even when controlling for health and demographic 
variables that may impact physical functioning.  Testosterone was not significantly 
associated with the physical component score of the SF-36.  It may be that, even though 
the subjects are not reporting an impact on their physical quality of life, lower 
testosterone levels are still influencing the actual performance. 
Some researchers have found that testosterone levels had specific consequences 
on quality of life for men with cancer (Greenfield et al., 2010), Alzheimer’s Disease (Lu 
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et al., 2006), HIV (Knapp et al., 2008), and opioid induced hypogonadism (Aloisi et al., 
2011).  Others have not seen an improvement in healthy men (Reddy et al., 2000).  Some 
studies have demonstrated that men with depression had low levels of testosterone 
(Almeida et al., 2008; McIntyre et al., 2006) and others have shown improvement of 
depressive symptoms with testosterone replacement therapy (Pope et al., 2003).  On the 
other hand, Seidman et al (2002) found testosterone to be related only to dysthymia (not 
major depression), while others have not found a relationship between testosterone and 
mood at all (Gray et al., 2005; Reddy et al., 2000).  This suggests that a relationship 
between testosterone and mood may not be causally linear. 
In the current sample of healthy middle-aged twins, testosterone was not 
significantly associated with quality of life or depression.  It may be that only 
testosterone levels below a certain threshold will impact mood.  It may also be that in a 
sample that is relatively free from disease, testosterone does not have an effect on quality 
of life or depression. 
Physical functioning was also explored for its putative role in quality of life and 
depression.  In the present sample, physical functioning was related to depression and 
quality of life in addition to testosterone.  This was true even after controlling for other 
health variables.  Higher values for both the physical component scores and mental health 
component scores were associated with better physical functioning.  In contrast, 
increased depressive symptoms were associated with decreased physical functioning.  All 
of these associations remained significant even after controlling for age, smoking, 
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hypertension, cardiovascular problems, and diabetes.  Physical functioning is an 
important component of one’s functional health.  In addition to the ability to care for 
oneself, decreased strength and physical ability may also impact leisure activities, 
decreasing one’s quality of life and possibly impacting mood.  For men, some have found 
that higher levels of physical activity are associated with lower occurrences of depressive 
symptoms (Reichert et al., 2011).        
One limitation of the present study is that the sample is relatively healthy, overall.  
It may be that, in a sample of less healthy men, the impact of lower testosterone is more 
apparent.  Another potential limitation is that all of the measurements were conducted at 
the same time.  Future research could focus on multiple time points to explore any 
relationship over time in testosterone, physical functioning, depression, and quality of 
life. 
  
26 
 
 
Table 2.3. 
Mixed Models without covariates included 
Dependent Variable / Independent Variable     Beta   SE          p 
Physical Functioning / Testosterone         .004  .00       .004 
Depression / Physical Functioning     -1.429 .25       .000 
PCS / Physical Functioning       2.472 .25       .000 
MCS / Physical Functioning           .992  .28       .000 
Depression / Testosterone       -.000  .01       .985 
PCS / Testosterone        .015  .01       .154 
MCS / Testosterone       -.000  .01       .985 
Note. Significant p-values (“p”) are presented in bold, “SE”=Standard Error, 
“PCS”=Physical composite score of the SF-36, “MCS”=Mental health composite score of 
the SF-36. 
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Table 2.4. 
Frequencies of Covariates 
           Frequency (n)            % of sample 
Current Smoking    297   24.0   
Hypertension     740   59.8     
Diabetes     136   11.0        
Cardiovascular Problems   214   17.3 
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Table 2.5. 
Mixed Models with covariates included 
Dependent Variable / Independent Variable     Beta   SE          p 
Physical Functioning / Testosterone      .004  .00       .002 
Depression / Physical Functioning     -1.281 .26       .000 
PCS / Physical Functioning       2.009 .25       .000 
MCS / Physical Functioning           .815  .29       .005 
Depression / Testosterone       -.003  .01       .731 
PCS / Testosterone        .012  .01       .215 
MCS / Testosterone        .001  .01       .904 
Note. Covariates included in the model were: age, smoking, hypertension, cardiovascular 
problems, and diabetes. Significant p-values (“p”) are presented in bold, “SE”=Standard 
Error, “PCS”=Physical component score of the SF-36, “MCS”=Mental health component 
score of the SF-36. 
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Chapter Three – Twin Analyses 
Introduction 
 Several genes have been implicated in depression, depressive symptoms, and 
vulnerability to depression (Aberg, Fandino-Losada, Sjoholm, Forsell, & Lavebratt, 
2011; Coskun, Arikan, Kilinc, Arikan, & Ekerbicer, 2013; Crisafulli et al., 2012; 
Goswami et al., 2012; Lavebratt, Aberg, Sjoholm, & Forsell, 2010; Lavebratt, Sjoholm, 
Partonen, Schalling, & Forsell, 2010; Lavebratt, Sjoholm, Soronen et al., 2010).  Specific 
genes that influence testosterone, quality of life, and physical functioning are less widely 
investigated.  However, as described in chapter 2, there are associations among some of 
these phenotypes.  Another way to investigate the relationships among testosterone, 
physical functioning, depression, and quality of life is through twin studies.  Twin studies 
have a unique advantage in that they allow researchers to decompose the variance of any 
complex trait into the genetic, shared environmental, and common environmental 
influences.    
 Monozygotic (MZ) twins are a result of a single zygote that has split which makes 
them genetically identical.  In contrast, dizygotic (DZ), or fraternal, twins are two 
separate fertilized eggs, making them only 50% genetically identical.  Because MZ twins 
share 100% of their genes and DZ share about half, MZ twins should be more similar 
than DZ twins in regards to genetically influenced traits. 
 The standard twin model (“ACE”) estimates the proportion of phenotypic 
variance that can be attributed to additive genetic effects (a
2
), common environmental 
effects (c
2
), and unique environmental effects (e
2
).  Common environmental effects are 
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those that make twins similar; unique environmental effects are individual-specific and 
make twins different.  The unique environmental parameter also includes error variance 
(Neale & Cardon, 1992).  There are several assumptions to the basic ACE model.  First, 
additive genetic factors correlate 1.0 for monozygotic (MZ) twins and 0.5 for dizygotic 
(DZ) twins.  Second, common environmental effects correlate 1.0 for both MZ and DZ 
twins.  There is an assumption that environments are equally shared for both MZ and DZ 
twins.  The equal environments assumption posits that any similarity due to common 
environments should be basically the same for both types of twins who are reared 
together.   Third, the unique environmental factors are uncorrelated for both MZ and DZ 
(Kremen et al., 2010).  And, finally, the variance in the phenotype attributable to the 
underlying latent genetic and environmental factors is fixed at 1.0, explaining 100% of 
the variance.  The ACE model can be extended beyond the univariate case to multivariate 
models that include the covariances among the measures.  Genetic correlations, shared 
environment correlations, and common environment correlations are derived from the 
bivariate model.  A genetic correlation between the phenotypes quantifies the overlap 
between genetic influences on each measure.  Similarly, the shared environment and 
common environment correlations reflect overlap in the environmental determinants of 
each measure.  These three factors combined determine the phenotypic correlation 
between measures, but without twin data, it is impossible to determine the extent to 
which each of the factors contributes to the observed correlation (Kremen et al., 2010).   
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Methods 
Participants 
 The participants included in the present analyses are the subset of the VETSA 
sample used to test HPA regulation, detailed in Chapter 1.  This included a final available 
sample of 778 (Franz et al., 2010) 
Procedure 
 The procedure of the present study is the same as the VETSA procedure described 
in detail in Chapter 1. 
Materials 
 The materials included in the present analyses are the same as those detailed in 
Chapter 1. 
Data Analysis: Twin Modeling 
 Bivariate genetic models were examined when there were statistically significant 
associations between phenotypes, as described in Chapter 2.  Cholesky decomposition 
models allow researchers to examine the specific genetic and environmental influences 
on phenotypes from those influences that are shared between phenotypes.  The extent to 
which genetic or environmental effects are shared by multiple traits is explained in the 
genetic or environmental covariance between them.  The bivariate models included: 
testosterone and physical functioning; physical functioning and depression; and physical 
functioning and quality of life.  In addition, a multivariate model including physical 
functioning, depression, and quality of life was explored.  The Cholesky model uses a 
triangular decomposition pattern where all variables load on one genetic factor, all of the 
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variables excluding the first load on a second genetic factor, all variables excluding the 
first two load on a third genetic factor, etc.  The same pattern is seen for the 
environmental factors. 
The parameter estimates were derived using a maximum-likelihood-based 
structural equation modeling program, Mx (Neale, Boker, Xie, & Maes, 1999).  Mx 
allows raw data to be fit to complex models, determining the relative contributions of 
genetic and environmental components (Purcell, 2002).  The models are compared to a 
saturated model that estimates means and variances of raw data.  In order to assess the fit, 
models can be compared for goodness of fit and parsimony using the Akaike’s 
Information Criterion (AIC; Akaike 1987) as well as the minus two log likelihoods         
(-2LLs) and chi-square tests.  For the AIC, lower values indicate preferred models that 
best fit the data.  Comparison of the -2LLs between the full model and the sub-models 
can also provide a measure of goodness-of-fit (Neale & Cardon, 1992).  
Hypotheses 
 There will be a significant genetic correlation between physical functioning and 
the average daily testosterone level. 
  There will be a significant genetic correlation between physical functioning and 
depression. 
 There will be a significant genetic correlation between physical functioning and 
the MCS. 
 There will be significant genetic correlations among all three phenotypes 
(physical functioning, depression, and the MCS) 
33 
 
 
Results 
 Table 3.6 shows the univariate parameter estimates for each of the phenotypes.  
For physical functioning, depression, and the MCS, the best fitting univariate model was 
the AE.  The AE models were not significantly different from the full ACE models but 
the AICs were lower for each of them.  This indicates that C can be dropped from the 
model, resulting in a better fit.  Dropping A from each of the models did result in a 
significant difference compared to the full ACE model and was a worse fit based on the 
AIC.  Therefore, the C can be drop whereas the A cannot.  The heritability was 49% for 
physical functioning, 38% for depression, 34% for the MCS, and 32% for testosterone.  
Note that the univariate model of testosterone is somewhat difficult to interpret due to 
possible over-inflation of the common environmental influences.  This is a result of the 
effects of assay batch which resulted in additional within-pair covariance for twins that 
were processed together (Panizzon et al., 2012).  
Table 3.7 demonstrates the model fitting estimates for the bivariate Cholesky 
decomposition of physical functioning and depression.  The best fitting model, as 
evidenced by the lowest AIC and a p > .05, is the AE model which means that C can be 
dropped for a better fitting model (see figure 3.8).  In this model, the heritability of 
physical functioning is 49.7% and the heritability of depression is 38.2%.  The shared 
genetic influence on the two phenotypes is significant with a correlation of -0.31 (95% 
confidence interval -0.46 to -0.15).  The phenotypic correlation for physical functioning 
and depression was -0.19 (95% confidence interval -0.25 to -0.13).  
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 Table 3.9 shows the model fitting estimates for the bivariate Cholesky 
decomposition of physical functioning and the mental health component score (MCS) of 
the sf36.  The best fitting model, as evidenced by the lowest AIC and a p > .05, is the AE 
model.  In this model, the heritability of physical functioning is 49.4% and the heritability 
of MCS is 34%.  The genetic overlap between the two phenotypes is significant with a 
correlation of 0.29 (95% confidence interval 0.11 to 0.46).  There is also a significant 
phenotypic correlation between the two (0.13; 95% confidence interval 0.07 to 0.20).  
See Figure 3.10 for the result of the best fitting, AE, model. 
 Table 3.11 shows the model fitting estimates for the bivariate Cholesky 
decomposition of physical functioning and testosterone.  Again, the best fitting model is 
the AE model.  However, while the phenotypic correlation is significant (0.13; 95% 
confidence interval 0.05 to 0.21), there is no significant genetic overlap between the 
determinants of physical functioning and the determinants of testosterone (see Figure 
3.12). 
 Table 3.13 shows the model fitting estimates for the trivariate Cholesky 
decomposition of physical functioning, depression, and the MCS.  The AE model is the 
best fitting model for these three variables.  Again, there are significant shared genetic 
influences between physical functioning and depression, physical functioning and quality 
of life, and depression and quality of life. The AE model best explains the sources of 
covariation between the three factors.   Figure 3.14 represents the best fitting model for 
the multivariate Cholesky.   
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Discussion 
The goal of the present study was to investigate whether there are shared 
determinants among physical functioning, testosterone, depression, and quality of life.  It 
was expected that there would be significant genetic correlations between the phenotypes.  
Indeed, significant genetic correlations were found between physical functioning and 
depression, physical functioning and quality of life, and depression and quality of life.  
The negative genetic correlations for phenotypes associated with depression are a result 
of the fact that higher numbers of depressive symptoms are associated with decreased 
physical functioning and/or quality of life.  
As evidenced by the trivariate Cholesky decomposition results, a model of 
additive genetic and non-shared environmental factors was the best explanation of the 
sources of covariation between the three phenotypes.  Based on this, 27% of the genetic 
variance in depression was due to specific genetic influence, unrelated to the SF-36 or 
physical function.  The heritability of depression is 38%.  Of this, 62.9% of the genetic 
influences of depression are shared with the mental health component score of the SF-36.  
Similarly, 10% of the genetic influences of depression are shared with those genes that 
influence physical functioning. 
In a rapidly aging population, it is critical to understand what factors contribute to 
successful aging and how.  Research has shown that one’s perception of successful aging, 
and rating of it, has been associated with higher functioning in cognitive, physical, and 
psychological domains (Blazer, 2000; Jeon & Dunkle, 2009; Li et al., 2011; Muthén, 
1998-2011; Scheetz, Martin, & Poon, 2012; Veer-Tazelaar, van Marwijk, Jansen, & al., 
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2008; Wright, 1921).  Resilience and depression have been shown to be of similar 
importance to the perception of successful aging as physical functioning (Caramaschi, 
Booij, Petitclerc, Boivin, & Tremblay, 2012).  To my knowledge, this is the first study to 
find that there are shared genetic determinants of physical function and depression as 
well as physical functioning and quality of life.   In this study, higher scores of the CES-
D were associated with lower physical functioning ability. 
However, there was not a significant genetic correlation between physical 
functioning and testosterone.  The phenotypic correlation between physical functioning 
and testosterone was still significant.  It may be that the relationship between the two is 
influenced by other variables.  Research in different areas has found that testosterone’s 
role may be influenced by other systems.  For example, much research has investigated a 
link between testosterone and cognition.  It remains unclear whether testosterone’s 
influence on cognition is primarily via androgen receptors or conversion to estradiol 
(Janowsky, 2006).  Furthermore, there may be an APOE by testosterone interaction such 
that cognition is influenced substantially more by testosterone levels only in individuals 
with the APOE ε4 allele (Panizzon et al., 2010).   
Testosterone counters the effects of cortisol.  Because of this, the brain may 
become vulnerable if cortisol is hyper-secreted in response to reduced levels of 
testosterone.  Noting the age-related decline of anabolic hormones, including 
testosterone, and the age-related increase in cortisol, Oettel, Hubler, and Patchev (2003) 
have proposed the idea of “age-related relative hypercortisolism”.  That is, manifestations 
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of hypercortisolism may occur with aging even if absolute cortisol levels are not elevated 
because the ratio of cortisol to testosterone may be increased.  It may be that this notion 
can help to explain some of the mixed findings regarding testosterone. Perhaps 
testosterone interacts with APOE or cortisol to influence physical functioning in addition 
to cognition.  Stress may also impact the functioning of the HPA axis (Sapolsky, 1990). 
The ability to control a stressful situation can also elicit different HPA responses 
(Parmigiani et al., 2006; Sapolsky, 1990). In some psychologically stressful situations, 
cortisol increases are accompanied by testosterone decreases (Schulz et al., 1996).   
 Research has shown that testosterone may interact with cortisol to play a role in 
coronary heart disease (Smith et al., 2005), with APOE genotype or estradiol to play a 
role in cognition (Janowsky, 2006; Panizzon et al., 2010), or with growth hormone to 
play a role in physical functioning (Giannoulis et al., 2006).  It may be that any of these 
factors, or other unknown factors, can explain a relationship between testosterone and 
physical functioning.  Further research is needed to explicate the role of testosterone in 
the aging male, particularly how it relates to physical functioning.  Additionally, it may 
be prudent to consider a number of variables, including other hormones, to determine if 
they operate in conjunction with testosterone.   
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Table 3.7. 
Model fitting estimates for bivariate Cholesky decomposition of Physical Functioning 
and Depression 
     -2LL   df  ∆ x2  ∆df  p  AIC 
SAT    6106.53 2195  ¯  ¯  ¯  ¯ 
ACE    6122.98 2212  16.45  17  0.49  -17.55 
AE    6125.79 2215  19.26  20  0.51  -20.74 
CE    6133.03 2215  26.50  20  0.15  -13.51 
Note. Best fitting models are presented in bold. “-2LL”=-2 times log likelihood, 
“df”=degrees of freedom, “∆ x2”=difference in chi-square, “∆df”=difference in degrees 
of freedom, “p”=probability, “AIC”=Akaike’s Information Criterion.   
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Figure 3.8. 
Heritability estimates and confidence intervals for the best fitting model of Physical 
Functioning and Depression 
 
 
 
Note. A = additive genetic influences; E = unique environmental influences  
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Table 3.9. 
Model fitting estimates for bivariate Cholesky decomposition of Physical Functioning 
and the Mental Health Component score of the sf36 
     -2LL   df  ∆ x2  ∆df  p  AIC 
SAT    6114.17 2188  ¯  ¯  ¯  ¯  
ACE    6138.66 2205  24.48  17  0.11   -9.52 
AE    6138.66 2208  24.48  20  0.22  -15.52 
CE     6150.16 2208  35.99  20  0.02  -4.01 
 
Note. Best fitting models are presented in bold. “-2LL”=-2 times log likelihood, 
“df”=degrees of freedom, “∆ x2”=difference in chi-square, “∆df”=difference in degrees 
of freedom, “p”=probability, “AIC”=Akaike’s Information Criterion.   
42 
 
 
 
Figure 3.10. 
Heritability estimates and confidence intervals for the best fitting model of Physical 
Functioning and the mental health component score of the SF-36 
 
 
Note. A = additive genetic influences; E = unique environmental influences; “MCS” = 
mental health component score of the SF-36
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Table 3.11. 
Model fitting estimates for bivariate Cholesky decomposition of Physical Functioning 
and Testosterone 
     -2LL   df  ∆ x2  ∆df  p  AIC 
SAT    4749.18 1713  ¯  ¯  ¯  ¯  
ACE    4768.16 1730  18.98  17  0.33  -15.02 
AE    4773.58 1733  24.40  20  0.23  -15.60 
CE    4777.90 1733  28.72  20  0.09  -11.28 
 
Note. Best fitting models are presented in bold. “-2LL”=-2 times log likelihood, 
“df”=degrees of freedom, “∆ x2”=difference in chi-square, “∆df”=difference in degrees 
of freedom, “p”=probability, “AIC”=Akaike’s Information Criterion. 
44 
 
 
 
Figure 3.12. 
Heritability estimates and confidence intervals for the best fitting model of Physical 
Functioning and Testosterone 
 
 
 
Note. A = additive genetic influences; E = unique environmental influences
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Table 3.13. 
Model fitting estimates for trivariate Cholesky decomposition of Physical Functioning, 
Depression, and the Mental Health component score of the sf36 
     -2LL   df  ∆ x2  ∆df  p  AIC 
SAT    9002.63 3393  ¯  ¯  ¯  ¯  
ACE    9042.82 3426  40.19  33  0.18  -25.81 
AE    9045.73 3432  43.09  39  0.30  -34.91 
CE    9057.43 3432  54.80  39  0.05  -23.20 
Note. Best fitting models are bolded. “-2LL”=-2 times log likelihood, “df”=degrees of 
freedom, “∆ x2”=difference in chi-square, “∆df”=difference in degrees of freedom, 
“p”=probability, “AIC”=Akaike’s Information Criterion. 
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Chapter Four – Path Analysis 
Introduction 
In chapter 2, relationships were found between several of the variables of interest: 
testosterone, physical functioning, depression, and quality of life.  With those results, the 
nature of the relationship between the variables is not taken into account.  In other words, 
there is an association between testosterone and physical functioning as well as between 
physical functioning and depression, but based solely on the mixed models, it is unknown 
which variables are affecting the other and whether the full picture of interplay among all 
three is more complicated.  Another way to investigate the causal/directional 
relationships among testosterone, physical functioning, depression, and quality of life is 
through a path analysis.  The path analysis technique was invented by geneticist Sewall 
Wright (1921) and has been widely used in the behavioral sciences to predict variances 
and covariances in a given model (Neale & Maes, 2004).  An advantage of path analysis 
is that it allows the researcher to make explicit hypotheses about the data, quantified by 
path coefficients, which can be compared directly to the observed data (Neale & Maes, 
2004).  The relationships between the variables are specified in advance to test the fit of 
the theoretical model to the data. 
Methods 
Participants 
 The participants included in the present analyses are the subset of the VETSA 
sample used to test HPA regulation, detailed in Chapter 1.  This included a final available 
sample of 778 (Franz et al., 2010) 
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Procedure 
 The procedure of the present study does not differ from the VETSA procedure 
described in detail in Chapter 1. 
Materials 
 The materials included in the present analyses are the same as those detailed in 
Chapter 1. 
Data Analysis: Path Analysis 
Structural equation modeling (SEM) was employed to explore the relationships 
among the phenotypes shown to be associated in Chapter 2.  The path analysis of SEM is 
a confirmatory technique and allows for the examination of complex relationships among 
variables (Wright, 1921).  The technique allows for related regression analyses to be 
explored simultaneously (Muthén, 1998-2011).  In addition, mediational processes can be 
explored through SEM (Ullman, 2001).  For example, it is possible for a given variable to 
be affected by a factor along different ‘paths’ (i.e. directly influenced by one variable 
and/or indirectly influenced only through the change in another, separate, variable). 
Therefore, both direct and indirect paths can be specified in advance to test the fit to the 
data (Muthén, 1998-2011).  Research has shown that the sample size available for these 
analyses is considered “very good” (Comrey & Lee, 1992). 
Two separate models were explored using the Mplus statistical package (Muthén, 
1998-2011).  In the first, testosterone was hypothesized as predictive of physical 
functioning, depression, and quality of life.  In addition, it was hypothesized that physical 
functioning also mediates the relationship between testosterone and depression and 
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testosterone and quality of life.  In the second model, physical functioning was 
hypothesized to be predictive of testosterone, depression, and quality of life.  In both of 
the models, the possibility of correlated data due to twins was accounted for.  This can be 
done with the “type equals complex” analysis command while clustering the twin pairs 
(Muthén, 1998-2011).  All variables were standardized. 
Hypotheses 
Model 1: 
 Model 1 is a hypothesized model in which testosterone is thought to influence 
physical functioning, depression and quality of life directly and to influence depression 
and quality of life through physical functioning (see Figure 4.15).  This model was 
initially developed based on the literature that suggests testosterone has an impact on 
physical functioning (Brown, 2008; Slowinska-Lisowska et al., 2010; Snyder et al., 1999; 
Srinivas-Shankar et al., 2010), depression (Almeida et al., 2008; Shores et al., 2004), and 
quality of life (Knapp et al., 2008; Lu et al., 2006).  Research also suggests that physical 
functioning can have an effect on depression and quality of life (Reichert et al., 2011).    
It is hypothesized that one mechanism for testosterone to impact depression and quality 
of life is through physical functioning. 
Model 2: 
Model 2 is a hypothesized model testing whether physical functioning influences 
testosterone, depression, and quality of life directly (see Figure 4.16).  This model was 
developed based on the results from chapter 2 in which testosterone was not associated 
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with depression and quality of life, but physical functioning was associated with all of the 
other phenotypes.      
Based on the associations, or lack thereof, found between the variables in chapter 
2, it was expected that Model 2 would fit this data better than Model 1.   
Results 
 Figure 4.17 shows the regression coefficients for each path in Model 1.  
Covariances between the observed dependent variables are also displayed.  Figure 4.18 is 
a representation of the significant paths of Model 1.  Table 4.19 displays the parameter 
estimates for Model 1.  Physical functioning is predictive of the physical health 
component score, the mental health component score, and depression.  In this model, 
physical functioning is also an outcome of a regression path in which testosterone 
predicts physical functioning.  There were no significant direct paths between 
testosterone and any other outcome.  Based on this model, a one unit change in 
testosterone is associated with a 0.140 unit change in the predicted value of physical 
functioning (p=0.001).  In addition, a one unit change in physical functioning is 
associated with: a 0.325 unit change in the predicted value of the PCS (p=0.000), a 0.092 
unit change in the predicted value of the MCS (p=0.035), and a -0.195 unit change in the 
predicted value of depression (p=0.000). 
 Model 2 represents a hypothesized relationship in which physical functioning is 
predictive of testosterone, depression, and the mental health and physical health 
component scores of the sf36.  Figure 4.20 displays the regression coefficients for each 
path.  The relationship between physical functioning and each of the outcomes was 
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significant (see Figure 4.21).  The physical health component score, the mental health 
component score, and depression also all covary significantly.  Testosterone does not 
significantly covary with any other outcome.  Parameter estimates for Model 2 can be 
found in Table 4.22.   
Contrary to expectations, Model 1 was a better fit to the raw data, based on the 
AIC for both models.  While not all of the regression paths were significant, overall 
Model 1 was the better fit.  The AIC value for Model 1 was 7386.06, while for Model 2 it 
was 9037.87.  Model 1 significantly predicts 11% of the variance in the physical 
component score of the SF-36 (r
2
=0.111, p<0.001) and 4% of the variance in depression 
(r
2
=0.040, p=0.028).  Model 1 also predicts 1% of the variance in the mental health 
component score of the SF-36 (r
2
=0.009, p=.284, ns) and 2% of the variance in physical 
functioning (r
2
=0.019, p=0.082, ns) but neither of these reach significance.  
Discussion 
The purpose of this study was to further explore the complex relationships among 
testosterone, physical functioning, depression, and quality of life.  In addition, a goal of 
the present study was to investigate the fit of two different models of relationships among 
four variables.  First, a model was fit in which testosterone is expected to influence 
physical functioning, depression and quality of life directly and to also influence 
depression and quality of life indirectly through physical functioning.  Second, a model 
was fit which hypothesized an impact of physical functioning on testosterone, depression, 
and quality of life.  It was expected that the second model would fit the data better based 
on the initial analyses with these variables.  
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The conclusion that the model in which testosterone is predictive of physical 
functioning is a better fit to the data is consistent with other research noting a 
unidirectional relationship between the two such that administration of testosterone can 
change physical fitness but that exercise does not impact testosterone levels (Slowinska-
Lisowska et al., 2010).  However, this model only predicts 2% of the variance in physical 
functioning.  Testosterone is not sufficient to significantly explain the variance in 
physical functioning.     
Finding significant direct effects from physical functioning on depression and 
quality of life is also consistent with some research.  For example, research has shown 
that in older individuals in Brazil, higher physical activity levels are associated with 
fewer depressive symptoms (Reichert et al., 2011) and that physical activity can improve 
quality of life in survivors of breast cancer (Caramaschi, Booij, Petitclerc, Boivin, & 
Tremblay, 2012).  (Panizzon et al., 2012).  
Interestingly, while testosterone did not directly impact any psychological 
variables, there are indirect effects on the variables through physical functioning.  
Therefore, it may be that testosterone is affecting them through physical functioning.  
That is, with higher levels of testosterone and consequently higher physical functioning, 
subjects may report better physical abilities, higher mental health, and fewer depressive 
symptoms.  This has consequences for an aging population for whom testosterone is 
decreasing steadily.  Furthermore, it may be that in an older population testosterone does 
have a direct impact on the psychological variables. 
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 This path analysis further explains a complex relationship among testosterone, 
physical functioning, depression, and quality of life.  A possible limitation to this work is 
that all variables were measured at one time point.  For future research, it would be 
interesting to see if testosterone is truly predictive of physical functioning, even after time 
has passed.  Similarly, a potential area to explore would be if, and how, these variables 
change together. 
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Figure 4.15. 
Model 1 – hypothesized model of relationships among testosterone, physical functioning, 
quality of life, and depression 
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Figure 4.16. 
Model 2 – hypothesized model of relationships among testosterone, physical functioning, 
quality of life, and depression 
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Table 4.19. 
Model results – Model 1 
           Estimate SE         p  
Regression 
Physical Functioning on Testosterone        .140  .041       .001 
PCS on Physical Functioning        .325  .041       .000 
PCS on Testosterone        .007  .037       .855 
MCS on Physical Functioning       .092  .043       .035 
MCS on Testosterone       -.021  .040       .608 
Depression on Physical Functioning     -.195  .046       .000 
Depression on Testosterone       .036  .038       .342 
Covariance 
MCS with PCS            .028  .045       .530 
Depression with PCS           -.181  .043       .000 
Depression with MCS       -.658  .066       .000 
Note. Significant p-values (“p”) are presented in bold, “SE”=Standard Error, 
“PCS”=Physical component score of the SF-36, “MCS”=Mental health component score 
of the SF-36. 
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Table 4.22. 
Model results – Model 2 
           Estimate SE         p  
Regression 
Testosterone on Physical Functioning        .137  .041       .001 
PCS on Physical Functioning        .288  .032       .000 
MCS on Physical Functioning      .118  .036       .001 
Depression on Physical Functioning     -.184  .037       .000 
Covariance 
PCS with Testosterone          -.001  .039       .973 
MCS with Testosterone          -.007  .041       .865 
MCS with PCS            .031  .040       .442 
Depression with Testosterone           .043  .040       .281 
Depression with PCS           -.174  .037       .000 
Depression with MCS       -.624  .059       .000 
Note. Significant p-values (“p”) are presented in bold, “SE”=Standard Error, 
“PCS”=Physical component score of the SF-36, “MCS”=Mental health component score 
of the SF-36.  
62 
 
 
Chapter Five – General Discussion 
 A great deal of research has explored a putative connection between testosterone 
and physical functioning, depression, and quality of life.  To my knowledge, this is the 
first study to explore all of these together in one sample of healthy middle aged men.  
This study was able to explore these concepts in several different ways.  First, through 
mixed models, associations were found between testosterone and physical functioning; 
physical functioning and depression; and physical functioning and quality of life.  All of 
these associations remained significant even when controlling for health and 
demographic factors (age, smoking, diabetes, high blood pressure, and cardiovascular 
problems) that may impact a relationship.  Higher average testosterone values were 
associated with better physical functioning.  Higher levels of physical functioning were 
associated with increased quality of life (higher values on both the mental health 
component score and the physical health component score) and lower numbers of 
depressive symptoms.  No relationship was found between testosterone and depression or 
testosterone and quality of life.  This is contrary to some literature that indicates an 
association (Aloisi et al., 2011; Greenfield et al., 2010; Knapp et al., 2008; Lu et al., 
2006; Pope et al., 2003; Shores et al., 2004).  It is interesting that testosterone was 
associated with physical functioning but not the physical component score of the SF-36.  
It may be that, in this sample, testosterone levels were affecting performance but not the 
perception of it. 
 Mixed models demonstrated an association between some of the variables but 
nothing else can be said about the nature of that relationship based on those analyses.  
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These concepts were explored further with biometrical modeling to determine the genetic 
and environmental contributions to the relationships.  Phenotypic correlations were again 
found among the same variables.  However, the Cholesky decompositions resulted in 
some interesting findings regarding the genetics of these associations.  In the best fitting 
models, in which the common environment is dropped, there were significant genetic 
correlations between physical functioning and depression and between physical 
functioning and the mental health component of the SF-36.  This indicates that the 
genetic influences on physical functioning overlap significantly with the genetic 
influences on depression and on quality of life.   
Some researchers have found  testosterone levels to be highly heritable, with 
estimates of up to 56% (Kuijper et al., 2007).  However, for infants, the interindividual 
variability in testosterone levels has been shown to be largely due to environmental 
factors (Caramaschi et al., 2012) while the heritability of testosterone is around 60% in 
adolescent males (Harris et al., 1998).  Furthermore, Harris et al. (1998) found no 
resemblance in father-son values.   Taken together, these findings suggest that different 
genetic factors may be expressed at different ages and that the heritability of testosterone 
may change with age.   In the univariate models of testosterone in the present sample, it is 
possible that the influence from the common environment is inflated due to the effects of 
assay batch.  In twins whose saliva was assayed together there was additional within-pair 
covariance.  While testosterone and physical functioning had a significant phenotypic 
correlation, the genetic correlation was not significant.  It is possible that an association 
between the two may be due to some other factor(s).  It may be that this is the reason why 
64 
 
 
the findings regarding testosterone and physical functioning are somewhat inconsistent in 
the literature. 
 In addition to age-related decline, obesity, inactivity, diet, disease, and trauma can 
all have a negative impact on testosterone levels (Brown, 2008).  While the age-related 
decline in testosterone is a well-established phenomenon, there are other factors that 
impact testosterone levels over the course of a man’s life.  For example, a number of 
studies have explored a relationship between testosterone levels and competition.  Quite a 
few have investigated martial arts and sporting events to measure the effect of the 
competition on testosterone (Gonzalez-Bono, Moya-Alboil, Martinez-Sanchis, & 
Salvador, 2002; Gonzalez-Bono, Salvador, Ricarte, Serrano, & Arnedo, 2000; Gonzalez-
Bono, Salvador, Serrano, & Ricarte, 1999; Parmigiani et al., 2006; Salvador, Simon, 
Suay, & Llorens, 1987; Salvador, Suay, Gonzalez-Bono, & Serrano, 2003; Salvador, 
Suay, Martinez-Sanchis, Simon, & Brain, 1999; Suay et al., 1999; van der Meij, Buunk, 
Almela, & Salvador, 2010).  Focusing on the anticipatory hormonal responses, Salvador 
et al. (2003) measured testosterone levels in 17 male judo players.  The measurements 
were collected prior to a competition and compared with measurements collected during 
a resting period.  In addition to testosterone, the authors measured cortisol and collected 
data regarding mood and expectations for the fight.  It was shown that the anticipatory 
response of testosterone was not significant overall.  However, for a group of participants 
who were more successful in their competition, there were significant increases in 
testosterone prior to the start as well as higher scores regarding their motivation to win 
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(Salvador et al., 2003).  In other words, the men who ultimately won the competitions 
had greater increases in testosterone in anticipation of the competition.     
A number of studies have found that it is more than just the competition that has 
an impact.  For an effect on testosterone, it also seems to be important how the individual 
thinks about the competition and its outcome.  In other words, testosterone is positively 
correlated with motivation to win (Salvador et al., 2003; Suay et al., 1999) and internal 
attribution of winning (Serrano, Salvador, Gonzalez-Bono, Sanchis, & Suay, 2001), but 
negatively correlated with external attributions (e.g., luck) of the outcome (Gonzalez-
Bono et al., 2000; Gonzalez-Bono et al., 1999).  Sometimes it may be that the control 
over a perceived stressful situation is more important than the outcome (Parmigiani et al., 
2006).  Parmigiani et al. (2006) found that free and total testosterone were higher in the 
losers of the fights.  Interestingly, these values were higher both before and after the 
fights.     
In the initial work in this area, Mazur and Lamb (1980) found testosterone levels 
to be higher in men who win tennis matches and men who receive the MD degree.  
Others have found a similar pattern in wrestlers (Elias, 1981), chess players (Mazur, 
Booth, & Dabbs, 1992), video game players (Mazur, Susman, & Edelbrock, 1997), and in 
fans of sporting events (Bernhardt, Dabbs, Fielden, & Lutter, 1998).  Some have 
suggested that an anticipatory rise in testosterone is preparing the individual for an 
upcoming competition.  However, Parmigiani et al. (2006) found higher testosterone only 
in individuals who subsequently lost and a number of studies have not shown a pre-fight 
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increase in testosterone at all (Filaire, Sagnol, Ferrand, Maso, & Lac, 2001; Gonzalez-
Bono et al., 1999; Passelergue & Lac, 1999).  Also, in psychologically stressful situations 
other than sports competitions, cortisol increases are accompanied by testosterone 
decreases (Schulz et al., 1996).  In the Schulz et al. (1996) study, the stressful situation 
was a one-day clinical evaluation in a lab rather than a competition. 
The early work regarding testosterone and competition has sparked the interest of 
researchers who have wondered about testosterone’s role in competition for a mate.  If 
testosterone is associated with the competition to find and attract a mate, it is reasonable 
to theorize that the levels of testosterone would differ between men who are married and 
those who are not.  In fact, there is a body of research that suggests differing levels of 
testosterone for men in committed relationships.  Married men have lower testosterone 
than unmarried men (Booth & Dabbs, 1993; Gray, Campbell, Marlowe, Lipson, & 
Ellison, 2004; Gray, Kahlenberg, Barrett, Lipson, & Ellison, 2002; Mazur & Michalek, 
1998) and unmarried men who are in a committed relationship have lower testosterone 
than men who are single (Burnham et al., 2003).  Furthermore, while testosterone is 
affected by the relationship status of men, that association is also influenced by the 
commitment to sexual exclusivity (McIntyre et al., 2006).  One longitudinal study found 
that men had higher testosterone when they were divorcing and that the level dropped 
again if they remarried (Mazur & Michalek, 1998).  Furthermore, there is evidence for 
reciprocity when considering testosterone and relationships in that testosterone can 
increase when men interact with an attractive woman (Roney, Mahler, & Maestripieri, 
2003). 
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Another factor that has been shown to impact a man’s testosterone level is 
whether or not he is a father.  Several studies have shown lower testosterone levels in 
men who have become fathers recently (Berg & Wynne-Edwards, 2001; Fleming, Corter, 
Stallings, & Steiner, 2002; Storey, Noseworthy, Delahunty, Halfyard, & McKay, 2011; 
Storey, Walsh, Quinton, & Wynne-Edwards, 2000).  Additionally, one study found that 
men with lower testosterone, even those who were not fathers, had more sympathy and an 
increased desire to respond to infant cries than fathers with higher testosterone (Fleming 
et al., 2002).  However, fathers who heard an infant cry showed an increased level of 
testosterone compared to fathers who did not hear an infant cry (Fleming et al., 2002).  
Storey et al. (2011) found that both low baseline testosterone levels and greater 
testosterone decreases over the testing days are associated with men being more 
responsive and attentive to their toddlers. 
In the present sample of healthy, middle-aged men, testosterone was not shown to 
be related to any variables but physical functioning.  There was not a significant genetic 
correlation between testosterone and physical functioning.  It may be that other factors 
are driving the relationship between the two.  A number of factors can affect the levels of 
testosterone for men.  It may be that a pattern of winning or losing, fatherhood, or 
relationships may change the trajectory of normal decline.  Furthermore, the somewhat 
transient nature of testosterone levels may make it difficult to establish consequences of 
lower values. 
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The trivariate Cholesky decomposition resulted in some interesting findings.  The 
best fitting model was one of additive genetic and non-shared environmental factors only.  
In this model, 27% of the genetic variance in depression was due to genetic influences 
specific to depression.  Sixty-three percent of the genetic influences on depression are 
shared with the genetic influences on the MCS.  An additional 10% of the heritability of 
depression can be explained by genetic influences that are shared with physical 
functioning.   
 Lastly, the path analysis technique of structural equation modeling was employed 
to further investigate the relationships.  The best fitting model was the model in which 
there was an indirect relationship between testosterone and depression and quality of life 
through physical functioning.  In this model, testosterone was hypothesized to impact 
physical functioning directly, for physical functioning to impact depression and quality of 
life directly, and for testosterone to have an indirect effect on depression and quality of 
life through physical functioning.  The path coefficients for the paths between 
testosterone and the psychological variables (depression and quality of life) were not 
significant.  This is consistent with the mixed model analyses of chapter 2 that did not 
find a relationship between these constructs.  However, the path to physical functioning 
was significant as were the subsequent paths to depression and quality of life.  It is 
interesting that when no other analyses (mixed models or twin analyses) have found an 
association between testosterone and depression or testosterone and quality of life, the 
best fitting path model showed an indirect effect.   
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 Some limitations to the present study are worth noting.  First, the sample is 
entirely male.  Given that a focus of this study was testosterone and its relationship to 
other variables, the gender of the participants could be considered a strength rather than a 
weakness.  However, it is not possible to generalize the impact of testosterone on 
physical ability or psychological functioning to women.  For women, higher free 
testosterone is associated with increased abdominal fat accumulation during early 
menopause (Cao, Zhang, Zou, & Xia, 2013).  In addition, as part of the larger problem of 
hyperandrogenism, higher serum testosterone may be involved in polycystic ovary 
syndrome (Coskun et al., 2013).  However, low levels of testosterone have been 
associated with diminished functional ovarian reserve (Gleicher et al., 2013).  It may be 
that women also have an optimal level of testosterone.  It is important to explore potential 
relationships between testosterone and other aspects of functioning for women as well. 
 Second, a possible concern is that all of the men are veterans as the sample is 
drawn from a twin registry made up of men who served in the military during the 
Vietnam Era.  However, the demographics of the VETSA sample are very similar to 
other men in their 50’s in terms of education, income, ethnicity, marital status, and 
employment (compared to United States census data from 2003).  Furthermore, while all 
VETSA participants were members of the military, the majority of them were not 
stationed in a war zone (Lyons et al., 2009).  Finally, all of the data were collected at one 
time point so no conclusions can be made regarding the longitudinal change or 
interaction of these variables. 
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 Research has explored a putative role for each of the variables included in this 
study in the aging process.  Even for men who are healthy, testosterone levels are known 
to decrease with age.  A consistent, slow, decline typically starts for men in their 20’s 
(Brown, 2008).  This can manifest as a clinical problem for men as early as their 50’s 
(Bain, 2007).  In addition, aging has been associated with decreased muscle mass and 
osteopenia for men (Morley, 2000).  Some measures of physical functioning are known 
to decrease with age (Carmeli et al., 2003; Carmelli & Reed, 2000; Frederiksen et al., 
2002; Jeune et al., 2006; Shechtman et al., 2004) particularly for men (Finkel et al., 
2003).  Upper body strength can be predictive of limitations in daily activities and 
disability (Katz, 1983; Lawton & Brody, 1969).  While depression is not a natural 
consequence of aging, some have found that older adults are more vulnerable to 
depression or depressive symptoms  (Blazer, 2000; Blazer, Burchett, Service, & al., 1991; 
Jeon & Dunkle, 2009; Li et al., 2011; Scheetz et al., 2012; Veer-Tazelaar et al., 2008).  
For a population that is rapidly aging, it is important to address the complex relationships 
among hormonal factors and various dimensions of functioning.     
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